Consolidated statement of income
In € millions |
Note |
|
2016* |
|
2017 |
||
|
|||||||
|
|
|
|
|
|
||
Continuing operations |
|
|
|
|
|
||
Revenue |
|
9,434 |
|
9,612 |
|
||
Cost of sales |
(5,098) |
|
(5,378) |
|
|||
Gross profit |
|
|
4,336 |
|
4,234 |
||
Selling expenses |
(2,336) |
|
(2,319) |
|
|||
General and administrative expenses |
(808) |
|
(781) |
|
|||
Research and development expenses |
(257) |
|
(270) |
|
|||
Other results |
(12) |
|
(39) |
|
|||
|
|
|
(3,413) |
|
(3,409) |
||
Operating income |
|
|
923 |
|
825 |
||
Financing income and expenses |
(91) |
|
(78) |
|
|||
Results from associates and joint ventures |
18 |
|
17 |
|
|||
Profit before tax |
|
|
850 |
|
764 |
||
Income tax |
|
(234) |
|
(253) |
|||
Profit for the period from continuing operations |
|
|
616 |
|
511 |
||
|
|
|
|
|
|
||
Discontinued operations |
|
|
|
|
|
||
Profit for the period from discontinued operations |
|
436 |
|
393 |
|||
Profit for the period |
|
|
1,052 |
|
904 |
||
|
|
|
|
|
|
||
Attributable to |
|
|
|
|
|
||
Shareholders of the company |
|
|
970 |
|
832 |
||
Non-controlling interests |
|
|
82 |
|
72 |
||
|
|
|
|
|
|
||
Profit for the period |
|
|
1,052 |
|
904 |
||
|
|
|
|
|
|
||
Earnings per share, in € |
|
|
|
|
|
||
Continuing operations |
|
|
|
|
|
||
Basic |
|
2.15 |
|
1.76 |
|||
Diluted |
|
2.14 |
|
1.75 |
|||
Discontinued operations |
|
|
|
|
|
||
Basic |
|
1.72 |
|
1.55 |
|||
Diluted |
|
1.71 |
|
1.54 |
|||
Total operations |
|
|
|
|
|
||
Basic |
|
3.87 |
|
3.31 |
|||
Diluted |
|
3.85 |
|
3.29 |
|||